Longboard Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $56,759,000.
Profit Margin
| 2020 | 0 | -14.4M | |
|---|---|---|---|
| 2021 | 0 | -27.73M | |
| 2022 | 0 | -43.09M | |
| 2023 | 0 | -54.42M |
LBPH Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 5K | 5K | 1K | 0 |
Gross profit | -5K | -5K | -1K | 0 |
Operating exp. | ||||
Research and development | 43.75M | 34.63M | 19.77M | 4.63M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 56.75M | 44.79M | 27.83M | 14.4M |
Operating income | -56.75M | -44.79M | -27.83M | -14.4M |
Other income (expenses), net | 2.33M | 853K | 42K | 0 |
Income before tax | -54.42M | -43.94M | -27.79M | -14.4M |
Income tax expense | 0 | -853K | -64K | -14.4K |
Net income | -54.42M | -43.09M | -27.73M | -14.4M |
Earnings per share | ||||
Basic EPS | -2.39 | -2.51 | -1.62 | -0.82 |
Diluted EPS | -2.39 | -2.51 | -1.62 | -0.82 |
| Data source | Data source | Data source |